IP Library Granted Patent US 10,905,592
Granted Patent B2
US 10,905,592 · App. 16/278,009 · Granted Feb 2, 2021

Patient interface for ophthalmologic diagnostic and interventional procedures

Inventors: Phillip Gooding (Mountain View, CA); Michael Wiltberger (Santa Clara, CA); Christine Beltran (San Jose, CA); Jonathan H. Talamo (Newton, MA)
Assignee: AMO Development, LLC
A61F9/009A61B3/0008A61B3/0025A61B3/102A61B3/14A61B90/39A61F9/0084A61F9/00814A61F9/00825A61B2090/3937A61B2090/3979A61B2090/3983A61F2009/0087A61F2009/00851A61F2009/00887A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,905,592
App. No.
16/278,009
Granted
Feb 2, 2021
Kind
B2
Abstract

An ophthalmic system may comprise an imaging device having a field of view oriented toward the eye of the patient; a patient interface housing defining a passage therethrough, having a distal end coupled to one or more seals configured to be directly engaged with one or more surfaces of the eye of the patient, and wherein the proximal end is configured to be coupled to the patient workstation such that at least a portion of the field of view of the imaging device passes through the passage; and two or more registration fiducials coupled to the patient interface housing in a predetermined geometric configuration relative to the patient interface housing within the field of view of the imaging device such that they may be imaged by the imaging device in reference to predetermined geometric markers on the eye of the patient which may also be imaged by the imaging device.

Claims (22)

1. A method for ophthalmic intervention on an eye of a patient having temporary geometric markers thereon indicative of the orientation of axis of the patient's eye, comprising:

using an imaging device having a field of view oriented toward the eye of the patient, imaging two or more registration fiducials in reference to the temporary geometric markers on the eye of the patient, the two or more registration fiducials being formed on an inner annulus of a patient interface housing disposed within the field of view of the imaging device, wherein the two or more registration fiducials include at least two registration fiducials either having different shapes or being made of different materials; and

processing image data generated via the imaging device for the two or more registration fiducials and the temporary geometric markers on the eye of the patient, including differentiating the image data for the at least two registration fiducials which either have different shapes or are made of different materials, to determine a position or an angular orientation of the eye relative to the patient interface housing based on locations of the two or more registration fiducials.

2. The method of claim 1 , further comprising directing a treatment laser beam through a passage of the patient interface housing and into the eye of the patient.

3. The method of claim 2 , wherein the treatment laser beam is a pulsed treatment beam with a pulse repetition rate between about 1 kHz and about 200 kHz, a wavelength between about 800 nm and about 1,100 nm, a pulse energy between about 1 microjoule and about 1,000 microjoules, and a pulse duration between about 100 femtoseconds and about 10 picoseconds.

4. The method of claim 1 , further comprising directing an illumination radiation from an illumination source toward the eye of the patient.

5. The method of claim 4 , wherein the illumination source is configured to direct at least a portion of the illumination radiation through the passage of the patient interface housing.

6. The method of claim 4 , wherein at least a portion of the patient interface housing is translucent to the illumination radiation, and the method further comprising directing at least a portion of the illumination radiation across the translucent portion of the patient interface housing toward the eye of the patient.

7. The method of claim 4 , wherein the illumination radiation is infrared radiation.

8. The method of claim 7 , wherein the fiducials comprise one or more materials that fluoresce in infrared radiation.

9. The method of claim 7 , wherein the fiducials comprise one or more materials that highly contrast in infrared radiation relative to other surrounding materials.

10. The method of claim 7 , wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

11. The method of claim 10 , wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

12. The method of claim 4 , wherein the illumination radiation is visible light radiation.

13. The method of claim 12 , wherein the fiducials comprise one or more materials that highly contrast in visible light radiation relative to other surrounding materials.

14. The method of claim 13 , wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

15. The method of claim 14 , wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

16. The method of claim 1 , wherein the imaging device comprises an optical coherence tomography system configured to measure the coherence of radiation scattered into an interferometer from the field of view.

17. The method of claim 16 , wherein the fiducials comprise one or more surface irregularities relative to other surrounding surfaces.

18. The method of claim 17 , wherein the one or more surface irregularities are selected from the group consisting of: a concave feature, a convex feature, a depressed edge, a depressed step, a projecting edge, a projecting step, and an intersection of lines.

19. The method of claim 1 , wherein the two or more fiducials are positioned on the inner annulus adjacent a distal end of the patient interface housing, the distal end being coupled to one or more seals around a periphery of passage of the patient interface housing configured to be directly engaged with an exterior surface of the eye of the patient.

20. The method of claim 1 , further comprising: processing the image data to determine a geometric relationship between an anatomical feature of the eye and the imaging device based on a geometric relationship between the two or more fiducials and the geometric markers.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: GOODING, PHILLIP; BELTRAN, CHRISTINE; TALAMO, JONATHAN
To: OPTIMEDICA CORPORATION
Reel/Frame 053017/0402 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: WILTBERGER, MICHAEL
To: OPTIMEDICA CORPORATION
Reel/Frame 053017/0626 →
MERGER Recorded Jun 23, 2020
From: OPTIMEDICA CORPORATION
To: AMO DEVELOPMENT, LLC
Reel/Frame 053017/0761 →
Continuity (6)
Continuation 15995651 · Jun 1, 2018
Continuation 15702492 · Sep 12, 2017
Continuation 15242348 · Aug 19, 2016
Continuation 14727708 · Jun 1, 2015
Continuation 13279155 · Oct 21, 2011
Related Publication 20190175409A1 · Jun 13, 2019